SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203 | -12.1% | 1,672 | -0.1% | 0.00% | 0.0% |
| Q1 2023 | $231 | +6.9% | 1,674 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $216 | -99.9% | 1,666 | -0.6% | 0.00% | -57.1% |
| Q4 2020 | $286,000 | +18.7% | 1,676 | -2.3% | 0.01% | +16.7% |
| Q3 2020 | $241,000 | -12.4% | 1,716 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $275,000 | +24.4% | 1,716 | 0.0% | 0.01% | +33.3% |
| Q4 2019 | $221,000 | -15.3% | 1,716 | 0.0% | 0.01% | -25.0% |
| Q2 2019 | $261,000 | +25.5% | 1,716 | -1.7% | 0.01% | -11.1% |
| Q1 2019 | $208,000 | -26.2% | 1,746 | 0.0% | 0.01% | -35.7% |
| Q3 2018 | $282,000 | +22.1% | 1,746 | 0.0% | 0.01% | +16.7% |
| Q2 2018 | $231,000 | – | 1,746 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |